Who owns Rigel Pharmaceuticals?
- CUSIP Number: 766559603
Tip: Access positions for across all investors
Analyze quarterly positions in Rigel Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Rigel Pharmaceuticals stock
Who bought or sold Rigel Pharmaceuticals this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Hughes Financial Services | 1.6k | $43k | 60% | Mar 2026 |
|
| Farther Finance Advisors | 752.00 | $21k | -3% | Mar 2026 |
|
| Advisory Services Network | 501.00 | $14k | -99% | Mar 2026 |
|
| EverSource Wealth Advisors | 218.00 | $5.9k | 707% | Mar 2026 |
|
| Bare Financial Services | 11.00 | $297.000000 | 100% | Mar 2026 |
|
| Essential Partners | 4.00 | $108.000000 | -60% | Mar 2026 |
|
| Huntington National Bank | 1.00 | $1.000000 | 0% | Mar 2026 |
|
| Rothschild Investment | 1.00 | $27.000000 | -88% | Mar 2026 |
|
Who sold out of Rigel Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Versant Capital Management | Mar 2026 | 237.00 | $6.4k |
| Triumph Capital Management | Dec 2025 | 200.00 | $8.6k |
| Parallel Advisors | Dec 2025 | 77.00 | $3.3k |